Aliso Viejo, Calif.-based Ellipse Technologies has filed for an IPO that could bring in as much as $75 million for its orthopedic surgery devices. Both of which are already on the market, Magec-Eos is designed for spinal bracing to curb scoliosis and the Precice limb-lenthening system for treating limb length discrepancies.
With these systems, physicians could ultimately magnetically control, move and adjust devices once they are implanted.
Ellipse said in an Oct. 16 regulatory filing that it estimates the addressable market for both the Magec-Eos and the Precice system at about $1.2 billion, according to Mass Device. The company said its pipeline includes devices designed to treat trauma, knee osteoarthritis and degenerative spine disease.
“We believe our proprietary MAGEC technology has the potential to become the standard of care for a wide range of orthopedic conditions,” Ellipse said in the filing.
